SCHEMBL3193166

SCHEMBL3193166

Cn1c(=O)c([N+](=O)[O-])c(Cl)c2cccnc21

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.62
ALDH1A1 P00352 6/20 0.62
NPSR1 Q6W5P4 5/20 0.62
LMNA P02545 3/20 0.62
NPC1 O15118 2/20 0.62
RAB9A P51151 2/20 0.62
TLR9 Q9NR96 2/20 0.62
SMN1; SMN2 Q16637 2/20 0.62
XBP1 P17861 1/20 0.62
PAX8 Q06710 1/20 0.62
MITF O75030 2/20 0.48
HTT P42858 2/20 0.48
AGTR1 P30556 1/20 0.48
FEN1 P39748 1/20 0.47
ATM Q13315 3/20 0.46
KDM4E B2RXH2 1/20 0.44
HSPD1 P10809 1/20 0.44
HSPE1 P61604 1/20 0.44
TNKS O95271 1/20 0.41
MEN1 O00255 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11371962 0.83 FEN1 (0.50) MAPTALDH1A1NPSR1LMNANPC1
SCHEMBL3195204 0.83 FEN1 (0.47) MAPTALDH1A1NPSR1LMNANPC1
SCHEMBL30541541 0.83 FEN1 (0.50) MAPTALDH1A1NPSR1LMNANPC1
SCHEMBL11365339 0.82 FEN1 (0.49) MAPTALDH1A1NPSR1LMNANPC1
SCHEMBL11365344 0.82 FEN1 (0.49) MAPTALDH1A1NPSR1LMNANPC1
SCHEMBL11365341 0.82 FEN1 (0.49) MAPTALDH1A1NPSR1LMNANPC1
SCHEMBL7270373 0.81 PDE4A (0.54) MAPTALDH1A1NPSR1LMNANPC1
SCHEMBL7271280 0.80 FEN1 (0.50) MAPTALDH1A1NPSR1LMNANPC1
SCHEMBL4851951 0.78 HSPD1 (0.67) MAPTALDH1A1NPSR1LMNANPC1
SCHEMBL29516939 0.77 MAPT (1.00) MAPTALDH1A1NPSR1LMNANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7678909-B1 2-[2-(3-Amino-cyclohexyl)-5-benzyl-4-oxo-4,5-dihydro-imidazo[4,5-c]pyridin-3-ylmethyl]-benzonitrile; type 2 diabetes mellitus, diabetic dislipidemia, impaired glucose tolerance; female infertility, osteoporosis, male contraception and neurological disorders TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-03-16 US disclosed
US-7169926-B1 Dipeptidyl peptidase inhibitors TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-01-30 US disclosed